GB1193197A - Cyclodextrin Polyethers and Process for Preparing the same - Google Patents

Cyclodextrin Polyethers and Process for Preparing the same

Info

Publication number
GB1193197A
GB1193197A GB53271/67A GB5327167A GB1193197A GB 1193197 A GB1193197 A GB 1193197A GB 53271/67 A GB53271/67 A GB 53271/67A GB 5327167 A GB5327167 A GB 5327167A GB 1193197 A GB1193197 A GB 1193197A
Authority
GB
United Kingdom
Prior art keywords
preparing
same
cyclodextrin
polyethers
cyclodextrin polyethers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB53271/67A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever Bestfoods North America
Original Assignee
Unilever Bestfoods North America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Bestfoods North America filed Critical Unilever Bestfoods North America
Publication of GB1193197A publication Critical patent/GB1193197A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/48—Polyethers
    • C08G18/487—Polyethers containing cyclic groups
    • C08G18/4883—Polyethers containing cyclic groups containing cyclic groups having at least one oxygen atom in the ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/01—Wetting, emulsifying, dispersing, or stabilizing agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Paper (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
GB53271/67A 1966-12-16 1967-11-22 Cyclodextrin Polyethers and Process for Preparing the same Expired GB1193197A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60214566A 1966-12-16 1966-12-16

Publications (1)

Publication Number Publication Date
GB1193197A true GB1193197A (en) 1970-05-28

Family

ID=24410151

Family Applications (1)

Application Number Title Priority Date Filing Date
GB53271/67A Expired GB1193197A (en) 1966-12-16 1967-11-22 Cyclodextrin Polyethers and Process for Preparing the same

Country Status (5)

Country Link
US (1) US3459731A (cg-RX-API-DMAC7.html)
BE (1) BE707947A (cg-RX-API-DMAC7.html)
FR (1) FR1548917A (cg-RX-API-DMAC7.html)
GB (1) GB1193197A (cg-RX-API-DMAC7.html)
NL (1) NL6716791A (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157446B2 (en) 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
WO2024037541A1 (zh) * 2022-08-18 2024-02-22 上海东大化学有限公司 基于环糊精的聚醚多元醇的合成方法

Families Citing this family (222)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026493B2 (ja) * 1980-01-29 1985-06-24 静岡大学長 ポリエーテルカーボネート
AU544564B2 (en) * 1980-08-09 1985-06-06 Sato Shokuhin Kogyo Kabushiki Kaisha Extracting beverages using cyclodextrin
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
EP0146841A3 (de) * 1983-12-17 1986-11-20 Consortium für elektrochemische Industrie GmbH Wasserlösliche Mischether des beta-Cyclodextrins und ein Verfahren zu ihrer Herstellung
EP0147685B1 (de) * 1983-12-17 1989-04-26 Hoechst Aktiengesellschaft Ether des beta-Cyclodextrins und ein Verfahren zu ihrer Herstellung
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4870060A (en) * 1985-03-15 1989-09-26 Janssen Pharmaceutica Derivatives of γ-cylodextrin
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US6407079B1 (en) * 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
US4920214A (en) * 1986-04-16 1990-04-24 American Maize-Products Company Process for producing modified cyclodextrins
IT1203968B (it) * 1987-04-24 1989-02-23 Bononi Ricerca Complessi di b-ciclodestrina ad attivita' antimicotica
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US4889634A (en) * 1988-10-04 1989-12-26 Gynex, Inc. Dialysate solution containing hydroxypropyl-beta-cyclodextrin and method of using same
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
US5173481A (en) * 1989-04-03 1992-12-22 The United States Of America As Represented By The Department Of Health And Human Services Preparation of specifically substituted cyclodextrins
WO1990012035A1 (en) * 1989-04-03 1990-10-18 Janssen Pharmaceutica N.V. Regioselective substitutions in cyclodextrins
US5096893A (en) * 1989-04-03 1992-03-17 The United States Of America As Represented By The Department Of Health And Human Services Regioselective substitutions in cyclodextrins
US4948395A (en) * 1989-09-12 1990-08-14 Advanced Separations Technologies Inc. Chiral separation media
US5064944A (en) * 1989-09-12 1991-11-12 Advanced Separation Technologies Inc. Chiral separation media
US5154738A (en) * 1989-09-12 1992-10-13 Advanced Separation Technologies, Inc. Chiral separation media
US5352717A (en) * 1990-05-04 1994-10-04 American Maize Technology Inc. Adhesives and sealants
US5258414A (en) * 1990-05-04 1993-11-02 American Maize Technology, Inc. Adhesives and sealants
US5063251A (en) * 1990-05-04 1991-11-05 American Maize-Products Company Blowing and curing of resins and plastics materials with cyclodextrin complexes
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5238927A (en) * 1990-11-30 1993-08-24 Brown Nesbitt D Hydrolytic stabilizer for unstable organic ions
NZ244424A (en) * 1991-09-23 1995-03-28 American Maize Prod Co Adhesive composition comprising plastics material, cyclodextrin and a blowing agent; method of increasing adhesive nature of composition
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
TW349870B (en) * 1993-09-30 1999-01-11 Janssen Pharmaceutica Nv An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
US5939060A (en) * 1994-08-12 1999-08-17 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US5578563A (en) * 1994-08-12 1996-11-26 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US5670475A (en) * 1994-08-12 1997-09-23 The Procter & Gamble Company Composition for reducing malodor impression of inanimate surfaces
MX9701122A (es) 1994-08-12 1997-05-31 Procter & Gamble Composicion para reducir la impresion de mal olor en superficies inanimadas.
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
US5534165A (en) * 1994-08-12 1996-07-09 The Procter & Gamble Company Fabric treating composition containing beta-cyclodextrin and essentially free of perfume
US5593670A (en) * 1994-08-12 1997-01-14 The Proctor & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
US5663134A (en) * 1994-08-12 1997-09-02 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US5714137A (en) * 1994-08-12 1998-02-03 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
US5492615A (en) * 1994-11-22 1996-02-20 Learonal Inc. Cyclodextrin stabilization of organic metal finishing additives in aqueous metal treating baths
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
DE69733664T3 (de) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
UA57734C2 (uk) * 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
US5879666A (en) * 1996-10-24 1999-03-09 The Procter & Gamble Company Methods and compositions for reducing body odor
US5897855A (en) * 1996-10-24 1999-04-27 The Procter & Gamble Company Methods and compositions for reducing body odor
US5882638A (en) * 1996-10-24 1999-03-16 The Proctor & Gamble Company Methods using uncomplexed cyclodextrin solutions for controlling environmental odors
US5911976A (en) * 1996-10-24 1999-06-15 The Procter & Gamble Company Compositions for reducing body odor
US5874067A (en) * 1996-10-24 1999-02-23 The Procter & Gamble Company Methods for controlling environmental odors on the body
US5780020A (en) * 1996-10-28 1998-07-14 The Proctor & Gamble Company Methods and compositions for reducing body odor
US5885599A (en) * 1996-10-28 1999-03-23 The Procter & Gamble Company Methods and compositions for reducing body odors and excess moisture
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
KR20080016756A (ko) * 1998-02-05 2008-02-21 노파르티스 아게 유기화합물 함유 조성물
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
ID28376A (id) 1998-11-10 2001-05-17 Janssen Pharmaceutica Nv Pirimidina yang menghambat replikasi hiv
US6358469B1 (en) 1998-12-01 2002-03-19 S. C. Johnson & Son, Inc. Odor eliminating aqueous formulation
MX339071B (es) * 1999-03-31 2016-05-09 Janssen Pharmaceutica Nv Almidon pregelatinizado en una formulacion de liberacion controlada.
BR0010279A (pt) 1999-05-04 2002-05-14 Janssen Phamaceutica N V éteres antifúngicos
DE19928676A1 (de) * 1999-06-23 2000-12-28 Basf Ag Polyisocyanat-Polyadditionsprodukte
DE19930553A1 (de) * 1999-07-02 2001-01-11 Wacker Chemie Gmbh Verfahren zur Herstellung von alkylierten Cyclodextrin-Derivaten
US6740713B1 (en) 1999-07-08 2004-05-25 Procter & Gamble Company Process for producing particles of amine reaction products
US6764986B1 (en) 1999-07-08 2004-07-20 Procter & Gamble Company Process for producing particles of amine reaction products
US6972276B1 (en) 1999-07-09 2005-12-06 Procter & Gamble Company Process for making amine compounds
US20050133174A1 (en) * 1999-09-27 2005-06-23 Gorley Ronald T. 100% synthetic nonwoven wipes
US6716805B1 (en) * 1999-09-27 2004-04-06 The Procter & Gamble Company Hard surface cleaning compositions, premoistened wipes, methods of use, and articles comprising said compositions or wipes and instructions for use resulting in easier cleaning and maintenance, improved surface appearance and/or hygiene under stress conditions such as no-rinse
EP1661503A3 (en) 1999-09-27 2008-01-02 The Procter and Gamble Company Hard surface cleaning compositions, premoistened wipes, methods of use, and articles comprising said compositions
US6479467B1 (en) * 1999-12-16 2002-11-12 Eastman Chemical Company Cyclodextrin ethers
CA2397661C (en) * 2000-03-01 2012-01-03 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
CA2406562C (en) 2000-05-08 2009-09-15 Janssen Pharmaceutica N.V. Hiv replication inhibiting pyrimidines and triazines
ES2265133T3 (es) * 2000-07-19 2007-02-01 THE PROCTER & GAMBLE COMPANY Composiciones limpiadoras.
US20020169090A1 (en) * 2000-07-19 2002-11-14 Foley Peter Robert Cleaning composition
US7645746B1 (en) 2000-11-13 2010-01-12 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
US7074824B2 (en) * 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
HUP0401748A3 (en) 2001-08-13 2011-03-28 Janssen Pharmaceutica Nv 2-amino-4,5-trisubstituted thiazolyl derivatives, process for their preparation and pharmaceutical compositions containing them
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US8101629B2 (en) * 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
US7638522B2 (en) * 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
WO2003076401A1 (en) 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
CA2476583C (en) * 2002-03-13 2011-07-05 Kristof Van Emelen Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
EP1487540A2 (en) * 2002-03-20 2004-12-22 Pharmacia Corporation Storage stable eplerenone formulation
DE10215942A1 (de) * 2002-04-11 2003-10-23 Bayer Ag Wässrige Formulierungen von (2-Hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorbutan-1-sulfonat
WO2003097011A1 (en) * 2002-05-17 2003-11-27 Eisai Co., Ltd. Compositions and methods using proton pump inhibitors
US20030224030A1 (en) 2002-05-23 2003-12-04 Hirotaka Uchiyama Methods and articles for reducing airborne particulates
US6710096B2 (en) 2002-07-22 2004-03-23 Basf Corporation Polyether polyol for foam applications
US7399856B2 (en) * 2002-08-09 2008-07-15 Janssen Pharmaceutica N.V. Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrile
EP1597237B1 (en) * 2003-02-07 2016-07-27 Janssen Pharmaceutica NV Pyrimidine derivatives for the prevention of HIV infection
CN102503903A (zh) 2003-02-07 2012-06-20 詹森药业有限公司 抑制hiv的1,2,4-三嗪
CL2004000303A1 (es) * 2003-02-20 2005-04-08 Tibotec Pharm Ltd Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
WO2004087101A2 (en) * 2003-03-28 2004-10-14 Ivax Corporation Oral formulations of cladribine
ES2584183T3 (es) * 2003-03-28 2016-09-26 Ares Trading S.A. Formulaciones de cladribina para suministro mejorado oral y transmucosa
ES2905724T3 (es) 2003-06-13 2022-04-11 Alnylam Europe Ag Acido ribonucleico bicatenario con elevada eficacia en un organismo
UA81305C2 (en) 2003-07-02 2007-12-25 Ares Trading Sa Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture
WO2005011618A2 (en) * 2003-07-31 2005-02-10 Ivax Corporation Methods for the treatment of male and female sexual dysfunction
ES2361835T3 (es) * 2003-09-25 2011-06-22 Janssen Pharmaceutica Nv Derivados de purina inhibidores de la replicación del hiv.
PT1691811E (pt) 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
CA2552356C (en) 2004-02-24 2013-11-19 The General Hospital Corporation Catalytic radiofluorination
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
AU2005323437B2 (en) 2004-04-30 2011-10-06 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a C5-modified pyrimidine
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
US7151121B2 (en) * 2004-05-26 2006-12-19 Danisco A/S Polyurethane containing a polyol composition comprising a highly branched polysaccharide, mix and process for preparation thereof
KR101195351B1 (ko) 2004-06-17 2012-10-29 인피니티 디스커버리, 인코포레이티드 Ｂｃｌ 단백질과 결합 파트너와의 상호작용을 억제하는화합물 및 방법
HRP20120327T1 (hr) 2004-07-28 2012-05-31 Janssen Pharmaceutica Nv Supstituirani indolil alkil amino derivati kao novi inhibitori histonske deacetilaze
AU2005271161B2 (en) * 2004-08-10 2011-05-12 Janssen Pharmaceutica N.V. HIV inhibiting 1,2,4-triazin-6-one derivatives
US8575342B2 (en) * 2004-09-30 2013-11-05 Tibotech Pharmaceuticals Ltd. HIV inhibiting 5-heterocyclyl pyrimidines
ATE542802T1 (de) * 2004-09-30 2012-02-15 Tibotec Pharm Ltd Hiv-inhibierende 5-substituierte pyrimidine
BRPI0517272A (pt) 2004-10-29 2008-10-07 Tibotec Pharm Ltd derivados de pirimidina bicìclicos de inibição de hiv
MX2007009015A (es) 2005-01-27 2007-09-18 Tibotec Pharm Ltd Derivados de 2-(4-cianofenilamino)pirimidina que inhibien el virus de la inmunodeficiencia humana.
BRPI0608381A2 (pt) * 2005-02-18 2009-12-29 Surface Logix Inc compostos aprimorados farmacocineticamente
JP2008530246A (ja) * 2005-02-18 2008-08-07 サーフェイス ロジックス，インコーポレイティド 機能性残基又は官能基を含む薬物動態学的に改善された化合物、及び上述の化合物を含む医薬組成物の製造方法
DK1858861T3 (da) * 2005-03-04 2010-11-08 Tibotec Pharm Ltd HIV-inhiberende 2-(4-cyanophenyl)-6-hydroxylaminopyrimidiner
US8669236B2 (en) * 2005-05-12 2014-03-11 The General Hospital Corporation Biotinylated compositions
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
WO2007041524A2 (en) 2005-09-30 2007-04-12 Ovation Pharmaceuticals, Inc. Novel parenteral carbamazepine formulation
US20070098148A1 (en) * 2005-10-14 2007-05-03 Sherman Kenneth N Aroma releasing patch on mobile telephones
DK1981875T3 (da) * 2006-01-19 2014-07-14 Janssen Pharmaceutica Nv Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
ES2327972T3 (es) * 2006-01-19 2009-11-05 Janssen Pharmaceutica, N.V. Derivados de aminofenil como nuevos inhibidores de histona deacetilasa.
EP1979326B1 (en) 2006-01-19 2012-10-03 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
ES2353725T3 (es) * 2006-03-30 2011-03-04 Tibotec Pharmaceuticals Pirimidinas sustituidas con 5-(hidroximetileno y aminometileno) que inhiben el vih.
AU2007233737B2 (en) 2006-03-30 2012-11-29 Janssen Sciences Ireland Uc HIV inhibiting 5-amido substituted pyrimidines
CN101522623B (zh) 2006-08-03 2013-06-12 塔夫茨大学信托人 无潮红烟酸类似物和其使用方法
CN101528293A (zh) 2006-08-30 2009-09-09 戴维·W·史密斯 施加单轴或者多轴刚度到挤出的材料的方法以及由此产生的产品
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US9006243B2 (en) * 2006-12-29 2015-04-14 Janssen R&D Ireland HIV inhibiting 6-substituted pyrimidines
US8318736B2 (en) * 2006-12-29 2012-11-27 Janssen R&D Ireland HIV inhibiting 5,6-substituted pyrimidines
US20080219927A1 (en) * 2007-01-18 2008-09-11 Thakur Ajit B Adenosine derivative formulations for medical imaging
EP2173942A1 (en) * 2007-06-28 2010-04-14 Buckman Laboratories International, Inc. Use of cyclodextrins for odor control in papermaking sludges, and deodorized sludge and products
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US8845627B2 (en) 2008-08-22 2014-09-30 Boston Scientific Scimed, Inc. Regulating pressure to lower temperature in a cryotherapy balloon catheter
EP3133160B1 (en) 2008-10-24 2018-12-12 Sarepta Therapeutics, Inc. Exon skipping compositions for dmd
BR122020021551B1 (pt) 2008-11-15 2021-09-21 Melinta Subsidiary Corp Composição farmacêutica antimicrobiana e seu uso
EP2216394A1 (en) * 2009-01-30 2010-08-11 The Procter & Gamble Company Method for perfuming fabrics
US9701177B2 (en) 2009-04-02 2017-07-11 Henkel Ag & Co. Kgaa Ceramic coated automotive heat exchanger components
AU2010319314C1 (en) 2009-11-13 2016-09-01 Sarepta Therapeutics, Inc. Antisense antiviral compound and method for treating influenza viral infection
US9068185B2 (en) 2010-03-12 2015-06-30 Sarepta Therapeutics, Inc. Antisense modulation of nuclear hormone receptors
EP3023496B1 (en) 2010-05-13 2020-07-29 Sarepta Therapeutics, Inc. Compounds which modulate interleukins 17 and 23 signaling activity
AU2011270719B2 (en) 2010-06-24 2015-09-24 Arisaph Pharmaceuticals, Inc. Niacin mimetics, and methods of use thereof
CA2802952A1 (en) 2010-06-24 2011-12-29 Arisaph Pharmaceuticals, Inc. Niacin mimetics, and methods of use thereof
WO2012100142A2 (en) 2011-01-20 2012-07-26 Cornell University Treatments for retinal disorders
US20150004126A9 (en) 2011-01-27 2015-01-01 Givaudan S.A. Compositions
CA2839593A1 (en) 2011-07-15 2013-01-24 Sarepta Therapeutics, Inc. Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites
WO2013086444A2 (en) 2011-12-08 2013-06-13 Sarepta Therapeutics, Inc. Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human lmna
AU2012355613A1 (en) 2011-12-23 2014-07-17 Novartis Ag Compounds for inhibiting the interaction of BCL2 with binding partners
CA2859873A1 (en) 2011-12-23 2013-06-27 Novartis Ag Compounds for inhibiting the interaction of bcl2 with binding partners
EA201491265A1 (ru) 2011-12-23 2014-11-28 Новартис Аг Соединения для ингибирования взаимодействия bcl-2 с партнерами по связыванию
AU2012355624A1 (en) 2011-12-23 2014-07-17 Novartis Ag Compounds for inhibiting the interaction of BCL2 with binding partners
AU2012355623A1 (en) 2011-12-23 2014-07-17 Novartis Ag Compounds for inhibiting the interaction of BCL2 with binding partners
HUE058834T2 (hu) 2012-02-15 2022-09-28 Cydex Pharmaceuticals Inc Elõállítási eljárás ciklodextrin-származékokhoz
MX353603B (es) 2012-02-28 2018-01-19 Cydex Pharmaceuticals Inc Composiciones de ciclodextrina alquilada y procesos para preparar y utilizar las mismas.
KR20150008406A (ko) 2012-05-15 2015-01-22 노파르티스 아게 Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체
WO2013171640A1 (en) 2012-05-15 2013-11-21 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
MX357305B (es) 2012-05-15 2018-07-04 Novartis Ag Compuestos y composiciones para inhibir la actividad de abl-1, abl-2, y bcr-abl1.
ES2670601T3 (es) 2012-05-15 2018-05-31 Novartis Ag Derivados de benzamida para la inhibición de la actividad de ABL1, ABL2 y BCR-ABL1
CA2883130A1 (en) 2012-08-31 2014-03-06 The General Hospital Corporation Biotin complexes for treatment and diagnosis of alzheimer's disease
WO2014066274A1 (en) 2012-10-22 2014-05-01 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
CN106414739A (zh) 2012-12-20 2017-02-15 萨雷普塔医疗公司 用于治疗肌营养不良症的改良的外显子跳跃组合物
NZ710385A (en) 2013-02-19 2016-10-28 Novartis Ag Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
US9217148B2 (en) 2013-03-14 2015-12-22 Sarepta Therapeutics, Inc. Exon skipping compositions for treating muscular dystrophy
EP3760720A1 (en) 2013-03-14 2021-01-06 Sarepta Therapeutics, Inc. Exon skipping compositions for treating muscular dystrophy
HK1220154A1 (zh) 2013-03-15 2017-04-28 Sarepta Therapeutics, Inc. 改进的用於治疗肌营养不良的组合物
AU2014292086B2 (en) 2013-07-19 2019-08-08 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
WO2015022663A1 (en) 2013-08-14 2015-02-19 Novartis Ag Compounds and compositions as inhibitors of mek
US9227969B2 (en) 2013-08-14 2016-01-05 Novartis Ag Compounds and compositions as inhibitors of MEK
WO2015022664A1 (en) 2013-08-14 2015-02-19 Novartis Ag Compounds and compositions as inhibitors of mek
US20150104348A1 (en) 2013-10-10 2015-04-16 The Iams Company Pet Deodorizing Composition
WO2015092634A1 (en) 2013-12-16 2015-06-25 Novartis Ag 1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
ES2699351T3 (es) 2014-01-17 2019-02-08 Novartis Ag Derivados de 1-piridazin/triazin-3-il-piper(-azina)/idina/pirolidina y composiciones de las mismas para inhibir la actividad de SHP2
JO3517B1 (ar) 2014-01-17 2020-07-05 Novartis Ag ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
WO2015107494A1 (en) 2014-01-17 2015-07-23 Novartis Ag 1 -(triazin-3-yi_/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2
US20170065589A1 (en) 2014-05-06 2017-03-09 Anthony G. Visco Methods of treating or preventing preterm labor
HUE063851T2 (hu) 2014-08-22 2024-02-28 Cydex Pharmaceuticals Inc Frakcionált alkilezett ciklodextrin készítmények és eljárás ezek elõállítására és alkalmazására
CN107257846A (zh) 2014-12-23 2017-10-17 路博润先进材料公司 用与两亲型交联剂交联的两亲型流变改性剂稳定化的衣物洗涤剂组合物
EP3237593A1 (en) 2014-12-23 2017-11-01 Lubrizol Advanced Materials, Inc. Laundry detergent compositions
HUE062732T2 (hu) 2015-04-20 2023-12-28 Univ Cornell Pórusos ciklodextrinpolimer-anyagok
EP3310779B1 (en) 2015-06-19 2019-05-08 Novartis AG Compounds and compositions for inhibiting the activity of shp2
WO2016203406A1 (en) 2015-06-19 2016-12-22 Novartis Ag Compounds and compositions for inhibiting the activity of shp2
ES2824576T3 (es) 2015-06-19 2021-05-12 Novartis Ag Compuestos y composiciones para inhibir la actividad de SHP2
US20190054113A1 (en) 2015-09-30 2019-02-21 Sarepta Therapeutics, Inc. Methods for treating muscular dystrophy
JP7042255B2 (ja) 2016-04-29 2022-03-25 サレプタ セラピューティクス， インコーポレイテッド ヒトｌｍｎａを標的にするオリゴヌクレオチド類縁体
PT3468972T (pt) 2016-06-14 2020-08-21 Novartis Ag Compostos e composições para inibir a atividade da shp2
KR20190024977A (ko) 2016-06-30 2019-03-08 사렙타 쎄러퓨틱스 인코퍼레이티드 근육 이상증에 대한 엑손 스킵핑 올리고머
WO2018026767A1 (en) 2016-08-02 2018-02-08 Virginia Commonwealth University Use of oxygenated cholesterol sulfates (ocs) to treat inflammatory skin disease and skin lesions
IL298681A (en) 2016-08-02 2023-01-01 Univ Virginia Commonwealth Preparations
ES3051834T3 (en) 2016-12-19 2025-12-30 Sarepta Therapeutics Inc Exon skipping oligomer conjugates for muscular dystrophy
PT4122497T (pt) 2016-12-19 2024-06-12 Sarepta Therapeutics Inc Conjugados oligoméricos de salto de exão para a distrofia muscular
NZ755416A (en) 2016-12-19 2023-05-26 Sarepta Therapeutics Inc Exon skipping oligomer conjugates for muscular dystrophy
ES2994451T3 (en) 2017-04-20 2025-01-24 Atyr Pharma Inc Compositions for treating lung inflammation
US11421048B2 (en) 2017-05-04 2022-08-23 Lubrizol Advanced Materials, Inc. Dual activated microgel
EA201991450A1 (ru) 2017-09-22 2019-12-30 Сарепта Терапьютикс, Инк. Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии
JP2020536060A (ja) 2017-09-28 2020-12-10 サレプタ セラピューティクス， インコーポレイテッド 筋ジストロフィーを処置するための併用療法
JP2020536058A (ja) 2017-09-28 2020-12-10 サレプタ セラピューティクス， インコーポレイテッド 筋ジストロフィーを処置するための併用療法
EP3687519A1 (en) 2017-09-28 2020-08-05 Sarepta Therapeutics, Inc. Combination therapies for treating muscular dystrophy
US10765760B2 (en) 2018-05-29 2020-09-08 Sarepta Therapeutics, Inc. Exon skipping oligomer conjugates for muscular dystrophy
EP4219717A3 (en) 2018-06-13 2023-12-20 Sarepta Therapeutics, Inc. Exon skipping oligomers for muscular dystrophy
AU2019312366B2 (en) 2018-07-26 2025-08-14 Atyr Pharma, Inc. Compositions and methods for treating NRP2-associated diseases
TW202449155A (zh) 2018-07-27 2024-12-16 美商薩羅塔治療公司 用於肌肉萎縮症之外顯子跳躍寡聚物
BR112021011018A2 (pt) 2018-12-13 2021-08-31 Sarepta Therapeutics, Inc. Conjugados de oligômero para exon skipping para distrofia muscular
AU2020204925B2 (en) 2019-01-03 2025-11-20 Cyclarity Therapeutics, Inc. Cyclodextrin dimers, compositions thereof, and uses thereof
CN113056516B (zh) 2019-02-14 2022-05-13 赛克洛珀股份有限公司 带有电荷的环糊精聚合物材料以及其制造和使用方法
EP3946376A1 (en) 2019-03-28 2022-02-09 Sarepta Therapeutics, Inc. Methods for treating muscular dystrophy with casimersen
WO2020214763A1 (en) 2019-04-18 2020-10-22 Sarepta Therapeutics, Inc. Compositions for treating muscular dystrophy
EP3987029A1 (en) 2019-06-19 2022-04-27 Sarepta Therapeutics, Inc. Methods for treating muscular dystrophy
CN115038723A (zh) 2019-11-18 2022-09-09 锡德克斯药物公司 烷基化环糊精组合物及其制备和使用方法
WO2021102080A1 (en) 2019-11-19 2021-05-27 Lubrizol Advanced Materials, Inc. Redeposition inhibiting polymers and detergent compositions containing same
CN114867831A (zh) 2019-12-19 2022-08-05 路博润先进材料公司 再沉积抑制性聚合物和含有所述再沉积抑制性聚合物的洗涤剂组合物
US12698348B2 (en) 2020-09-24 2026-08-04 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
EP4286439A1 (en) * 2021-01-29 2023-12-06 Tokuyama Corporation Hollow microballoon
EP4233837A1 (en) 2022-02-24 2023-08-30 CellAct Pharma GmbH Solid and oral etoposide toniribate compositions
EP4493693A1 (en) 2022-03-17 2025-01-22 Sarepta Therapeutics, Inc. Phosphorodiamidate morpholino oligomer conjugates
EP4593855A1 (en) 2022-09-28 2025-08-06 Altos Labs, Inc. Expression of regeneration factors in aged/senescent cells
AU2023420130A1 (en) 2022-12-30 2025-08-14 Cornell University Acid cyclodextrins for the treatment of lipofuscin buildups and ocular diseases
KR20250161522A (ko) 2023-01-12 2025-11-17 사이클로퓨어, 인코포레이티드 중합체 시클로덱스트린 흡착제의 재생
CN117683501B (zh) * 2023-12-11 2026-07-07 广州白云科技股份有限公司 一种环保长效防霉的硅烷改性聚醚密封胶及其制备方法
CN118931521B (zh) * 2024-10-12 2024-12-27 四川省贝特石油技术有限公司 一种非表面活性剂起泡的自修复高质量微泡沫压裂液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2518135A (en) * 1946-11-01 1950-08-08 Univ Ohio State Res Found Uniformly 2-substituted glucopyranose polymers
US2996551A (en) * 1953-09-24 1961-08-15 Petrolite Corp Certain polyepoxide-modified oxyalkylation derivatives being obtained in turn by oxyalkylation of certain polyols having at least three hydroxyls
US2761247A (en) * 1953-12-10 1956-09-04 Du Pont Process for conditioning soil with polysaccharide xanthates
US2945025A (en) * 1954-05-24 1960-07-12 Petrolite Corp Certain oxyalkylated glucoses
US2900268A (en) * 1956-11-15 1959-08-18 John C Rankin Process for preparing hydroxyalkylated cereal flour
US3042666A (en) * 1958-02-26 1962-07-03 Ici Ltd Polyether derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157446B2 (en) 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
WO2024037541A1 (zh) * 2022-08-18 2024-02-22 上海东大化学有限公司 基于环糊精的聚醚多元醇的合成方法

Also Published As

Publication number Publication date
US3459731A (en) 1969-08-05
FR1548917A (cg-RX-API-DMAC7.html) 1968-12-06
NL6716791A (cg-RX-API-DMAC7.html) 1968-06-17
BE707947A (cg-RX-API-DMAC7.html) 1968-06-14

Similar Documents

Publication Publication Date Title
CA1005200A (en) Pencil sheath compositions, method and apparatus for making pencils, and the resulting product
GB1326550A (en) Apparatus for the continuous preparation of expanded tobacco
GB1216840A (en) Novel starch derivatives, processes for making them, compositions based on the novel starch derivatives and method of making the compositions
GB1299932A (en) Inverting turret
ES351577A1 (es) Procedimiento para la preparacion de hidrocarburo undeca- trienico.
CA940919A (en) 11.beta.,13.beta.-DIALKYLGONA-1,3,5(10)-TRIENE-3-OL 3-CYCLOALKYL ETHERS AND PROCESSES FOR THEIR PREPARATION
ES454479A1 (es) Procedimiento para recubrir sustratos con un aminoplasto mo-dificado
AU1748370A (en) Thiphen ethers and process for preparing them
AU452519B2 (en) Corrosion-resistant electrocoated articles and process for preparing same
CA677235A (en) Coated fibrous products, compositions and methods for making them
CA743143A (en) 1,1-dimethyltetrahydronaphthindans and process for preparing same
BRANCHED PUBLISHER'S NOTICE
GB1272562A (en) Pharmaceutical compositions comprising phloroglucinol ethers
CA819071A (en) Nutrient compositions and process for preparing same
CA825585A (en) Paper sizing compositions and paper sized therewith
CA785675A (en) Coating composition, method and product
CA971105A (en) VETERINARY COMPOSITIONS CONTAINING 6.alpha.,9.alpha.-DIFLUORO-16.alpha.-METHYLPREGNA-1,4-DIENE-11.beta.,17.alpha.,21-TRIOL-3,20-DIONE AND METHODS
AU6208469A (en) Component for use in preparing antifoulant coating composition, method of preparing antifoulant coating compositions and resulting product
CA746500A (en) 6-chloro-.delta.3,5-steroid derivatives and process for their manufacture
AU428279B2 (en) Production of neomycin, nutrient medium used therein and process for preparing medium
CA806133A (en) Embossed resinous compositions and process for preparing same
CA720293A (en) Shaped articles containing cellulose crystallite aggregates having an average level-off d.p.
AU3244468A (en) IMPROVEMENTS IN OR RELATING TO PNEUMATIC TYRES. Application No. 39, 020/72 was lodged onthe 16th February 1972 asan additional to this application
AU5741469A (en) Pentol, derivatives, process for their manufacture and compositions containing them
CA930229A (en) Products, processes and compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees